RNAC Past Earnings image   This RNAC past earnings page last updated 5/20/2024
RNAC Past Earnings
PeriodPast Earnings DateGAAP
Q1 20245/8/2024-10.500
Q4 20233/7/2024-41.700
Q3 202311/13/2023-1.800
Q2 20238/17/2023-0.070
Q1 20235/4/2023-0.140
Q4 20223/2/20230.040
Q3 202211/3/2022-0.050
Q2 20228/4/20220.060
Q1 20225/5/20220.080
Q4 20213/10/20220.030
Q3 202111/9/2021-0.160
Q2 20218/12/20210.000
Q1 20215/13/2021-0.220
Q4 20203/11/2021-0.140
Q3 202011/5/2020-0.090
Q2 20208/6/2020-0.250
Q1 20205/7/2020-0.210
Q4 20193/12/2020-0.280
Q3 201911/8/2019-0.260
Q2 20198/8/2019-0.370
Q1 20195/9/2019-0.310
Q4 20183/15/2019-0.65
Q3 201811/8/2018-0.71
Q2 20188/8/2018-0.84
Q1 20185/9/2018-0.71
Q4 20173/15/2018-0.88
Q3 201711/7/2017-0.66
Q2 20178/11/2017-0.85
Q1 20175/11/2017-0.82
Q4 20163/27/2017-0.77
Q3 201611/10/2016-0.43
Q2 20168/9/2016-2.75
RNAC Past Revenue
PeriodPast Earnings DateGAAP
Q1 20245/8/20240.01B
Q4 20233/7/20240.01B
Q3 202311/13/20230.01B
Q2 20238/17/20230.01B
Q1 20235/4/20230.01B
Q4 20223/2/20230.02B
Q3 202211/3/20220.02B
Q2 20228/4/20220.04B
Q1 20225/5/20220.03B
Q4 20213/10/20220.03B
Q3 202111/9/20210.02B
Q2 20218/12/20210.02B
Q1 20215/13/20210.01B
Q4 20203/11/20210.01B
Q3 202011/5/20200.00B
Q2 20208/6/2020NA
Q1 20205/7/2020NA
Q4 20193/12/20200.01B
Q3 201911/8/2019NA
Q2 20198/8/20190.01M
Q1 20195/9/20190.01M
Q4 20183/15/2019903000
Q3 201811/8/2018NA
Q2 20188/8/2018NA
Q1 20185/9/2018NA
Q4 20173/15/201817000
Q3 201711/7/201727000
Q2 20178/11/201726000
Q1 20175/11/2017137000
Q4 20163/27/20172.93M
Q3 201611/10/20161.05M
Q2 20168/9/20162.02M
Quotes delayed 20 minutes

Email EnvelopeFree RNAC Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Cartesian Therapeutics (RNAC) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

RNAZ Past Earnings
RNXT Past Earnings
RPHM Past Earnings
RPID Past Earnings
RPRX Past Earnings
RSLS Past Earnings
RUBY Past Earnings
RVMD Past Earnings
RVNC Past Earnings
RVPH Past Earnings

RNAC Past Earnings Q&A

What was the best and worst RNAC past earnings results?
For Cartesian Therapeutics, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest RNAC past earnings result in our data set was 0.080/share posted in Q1 2022, while the lowest was in Q4 2023 when RNAC posted -41.700/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q2 2022 when RNAC reported 0.04B in revenue, while the quarter with the lowest revenue in our data set was Q2 2020 at NA of revenue.

  Suggested answer: There are 32 RNAC past earnings results in our data set.

On this page we presented the RNAC past earnings date information for Cartesian Therapeutics. Reviewing that RNAC Past Earnings for the company, we see that the highest past earnings result in our data set was in Q1 2022, when RNAC posted gaap of 0.080/share. Meanwhile the lowest RNAC past earnings result was in Q4 2023, when RNAC posted gaap of -41.700/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q2 2022 when RNAC reported 0.04B in revenue, while the smallest revenue quarter was Q2 2020 when RNAC reported NA in revenue.

Any self directed investor doing their due diligence on RNAC or any other given stock can benefit from researching all of the Cartesian Therapeutics past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate Cartesian Therapeutics past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for RNAC. Thanks for visiting, and the next time you need to research RNAC past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: Institutional Holders of EXA, FRAF Dividend Growth Rate, SKX Stock Predictions.


RNAC Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
Wait! Don't leave yet.
Want to receive our latest research absolutely free?

Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.